HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

mocetinostat

undergoing phase II clinical trials for treatment of cancer
Also Known As:
MG 0103; MG 4230; MG 4915; MG 5026; MG-0103; MG-4230; MG-4915; MG-5026; MG0103; MG4230; MG4915; MG5206; MGCD 0103; MGCD-0103; MGCD0103; N-(2-aminophenyl)-4-((4-pyridin-3-ylpyrimidin-2-ylamino)methyl)benzamide
Networked: 71 relevant articles (11 outcomes, 19 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Li, Zuomei: 6 articles (12/2011 - 04/2008)
2. Younes, Anas: 5 articles (01/2017 - 09/2010)
3. Martell, Robert E: 5 articles (12/2011 - 04/2008)
4. Garcia-Manero, Guillermo: 4 articles (06/2011 - 08/2008)
5. Besterman, Jeffrey M: 4 articles (08/2008 - 04/2008)
6. Wang, J: 3 articles (01/2021 - 10/2014)
7. Choy, Edwin: 3 articles (01/2019 - 01/2017)
8. Pollock, Raphael: 3 articles (01/2019 - 01/2017)
9. Potvin, Diane: 3 articles (01/2019 - 01/2017)
10. Copeland, Amanda: 3 articles (01/2017 - 09/2010)

Related Diseases

1. Pain (Aches)
2. Hodgkin Disease (Hodgkin's Disease)
3. Fibrosis (Cirrhosis)
4. Cardiomegaly (Heart Hypertrophy)
5. Neoplasms (Cancer)

Related Drugs and Biologics

1. Histone Deacetylase Inhibitors
2. entinostat (MS 275)
3. Gemcitabine
4. Histone Deacetylases (Histone Deacetylase)
5. Valproic Acid (Depakote)
6. Vorinostat
7. Butyric Acid (Butanoic Acid)
8. Histones (Histone)
9. Proteins (Proteins, Gene)
10. Collagen

Related Therapies and Procedures

1. Therapeutics
2. Stents
3. Laminectomy